Last reviewed · How we verify
Ciprodex and 2% NAC
Ciprodex and 2% NAC is a Small molecule drug developed by St. Paul's Hospital, Canada. It is currently FDA-approved. Also known as: Ciprodex with 2% N-Acetylcysteine.
At a glance
| Generic name | Ciprodex and 2% NAC |
|---|---|
| Also known as | Ciprodex with 2% N-Acetylcysteine |
| Sponsor | St. Paul's Hospital, Canada |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ciprodex and 2% NAC CI brief — competitive landscape report
- Ciprodex and 2% NAC updates RSS · CI watch RSS
- St. Paul's Hospital, Canada portfolio CI
Frequently asked questions about Ciprodex and 2% NAC
What is Ciprodex and 2% NAC?
Ciprodex and 2% NAC is a Small molecule drug developed by St. Paul's Hospital, Canada.
Who makes Ciprodex and 2% NAC?
Ciprodex and 2% NAC is developed and marketed by St. Paul's Hospital, Canada (see full St. Paul's Hospital, Canada pipeline at /company/st-paul-s-hospital-canada).
Is Ciprodex and 2% NAC also known as anything else?
Ciprodex and 2% NAC is also known as Ciprodex with 2% N-Acetylcysteine.
What development phase is Ciprodex and 2% NAC in?
Ciprodex and 2% NAC is FDA-approved (marketed).
Related
- Manufacturer: St. Paul's Hospital, Canada — full pipeline
- Also known as: Ciprodex with 2% N-Acetylcysteine
- Compare: Ciprodex and 2% NAC vs similar drugs
- Pricing: Ciprodex and 2% NAC cost, discount & access